Oxetorone: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 65: Line 65:
{{Reflist|2}}
{{Reflist|2}}


[[Antimigraine preparations]]
{{Antimigraine preparations}}
[[Category:Drugs]]
[[Category:Drugs]]

Revision as of 18:42, 12 February 2014


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

For patient information about Oxetorone, click here.

Synonyms / Brand Names: ®,

Overview

Oxetorone
Ball-and-stick model
Ball-and-stick model
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
CAS Number
PubChem CID
UNII
KEGG
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC21H21NO2
Molar mass319.40 g/mol
3D model (JSmol)
  (verify)

Oxetorone is an antimigraine agent.[1]

Association with hyperprolactinemia has been described.[2] [3]

References

  1. Massiou H (2000). "[Prophylactic treatments of migraine]". Rev. Neurol. (Paris) (in French). 156 Suppl 4: 4S79–86. PMID 11139754.
  2. Pradalier A (December 1996). "Hyperprolactinaemia and depression induced by oxetorone". Cephalalgia. 16 (8): 560–1. doi:10.1046/j.1468-2982.1996.1608560.x. PMID 8980859.
  3. "Oxetorone - Wikipedia, the free encyclopedia".

Template:Antimigraine preparations